NCT01132131

Brief Summary

The Emergency Ward Center in Oslo has the last two years used a questionnaire to identify patients who qualify for treatment of acute cystitis by the use of a delegation form. The aim of the study is to evaluate this practice, the primary objective being to evaluate if in a selected patient group the treatment outcome after identifying patients with probable acute cystitis by delegation form will be as good or better than the treatment received after a regular doctor's consultation. The planned study will also investigate which symptoms, signs and laboratory findings that coincide with significant bacteruria. The reference standard will be a microbiological culture of every patients urine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
443

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Aug 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 20, 2010

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 27, 2010

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2010

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

February 2, 2012

Status Verified

February 1, 2012

Enrollment Period

1.3 years

First QC Date

May 20, 2010

Last Update Submit

February 1, 2012

Conditions

Keywords

Urinary tract infectionCystitisBacteruria

Outcome Measures

Primary Outcomes (2)

  • Number of patients who are clinically and bacteriologically free of symptoms of urinary tract infection.

    The antibiotic treatment given will be of three days length.

    6 days after start of treatment.

  • Number of patients who are clinically and symptomatologically free of symptoms.

    The antibiotic treatment will be of three days length

    10 days after start of treatment

Study Arms (2)

Delegation form

ACTIVE COMPARATOR
Other: Delegation form

Regular doctor's consultation

ACTIVE COMPARATOR
Other: Delegation form

Interventions

The study aims to compare the use of a delegation form to identify patient's who qualify for antibiotic treatment for suspected acute cystitis with a regular doctor's consultation. The key outcomes are lack of bacteruria and symptoms of UTI at followup times.

Delegation formRegular doctor's consultation

Eligibility Criteria

Age16 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Females 16-55 years
  • Dysuria
  • Increased frequency of urination

You may not qualify if:

  • Pregnant
  • Breastfeeding child \< 1 month of age
  • Diabetes
  • Kidney disease
  • Fever
  • Poor general condition
  • Backpain
  • Abdominal pain
  • Increased amount of vaginal secretions
  • Vaginal itching or pain
  • Urinary tract infection in the last four weeks
  • Use of urinary catheter in the last four weeks
  • Symptoms lasting more than seven days
  • Ongoing antibiotic treatment
  • Allergy to penicillin
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Legevakten i Oslo

Oslo, Oslo County, 0182, Norway

Location

Related Publications (1)

  • Bollestad M, Grude N, Lindbaek M. A randomized controlled trial of a diagnostic algorithm for symptoms of uncomplicated cystitis at an out-of-hours service. Scand J Prim Health Care. 2015 Jun;33(2):57-64. doi: 10.3109/02813432.2015.1041827. Epub 2015 May 11.

MeSH Terms

Conditions

Urinary Tract InfectionsCystitis

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesUrinary Bladder Diseases

Study Officials

  • Morten Lindbaek, Md PhD

    University of Oslo

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Md

Study Record Dates

First Submitted

May 20, 2010

First Posted

May 27, 2010

Study Start

August 1, 2010

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

February 2, 2012

Record last verified: 2012-02

Locations